How does MYCN change the way genetic information is read?
Understanding how the MYCN protein changes the amounts of other proteins in the cell by changing the way DNA is processed and translated.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Understanding how the MYCN protein changes the amounts of other proteins in the cell by changing the way DNA is processed and translated.
Finding the biological differences between teenage and young adult cancers cells compared to older adults.
Understanding how leukaemia cells enlist immune system cells to help them survive chemotherapy.
Investigating how a protein changes the way leukaemia cells behave in babies.
Looking at how a process called 'cut-and-run' leads to genetic errors, and how those errors could be prevented in order to prevent relapse in childhood leukaemia.
Looking at a new subtype of leukaemia, called CML-like Ph+ALL, to see how best to diagnose and treat it.
Find out how JMML cells are able to switch off the immune system, causing relapse.
Finding out what makes ALL more high-risk, such as age of diagnosis or type of initial treatment.
Using models to find out how high risk leukaemia cells grow and become resistant to treatment.